Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 310

1.

Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy for oropharyngeal cancer: a matched-pair analysis.

Al-Mamgani A, Van Rooij P, Tans L, Teguh DN, Levendag PC.

Technol Cancer Res Treat. 2013 Apr;12(2):123-30. doi: 10.7785/tcrt.2012.500305. Epub 2012 Oct 19.

PMID:
23098281
2.

The impact of treatment modality and radiation technique on outcomes and toxicity of patients with locally advanced oropharyngeal cancer.

Al-Mamgani A, van Rooij P, Verduijn GM, Mehilal R, Kerrebijn JD, Levendag PC.

Laryngoscope. 2013 Feb;123(2):386-93. doi: 10.1002/lary.23699.

PMID:
23404489
3.

Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer.

Lambrecht M, Nevens D, Nuyts S.

Strahlenther Onkol. 2013 Mar;189(3):223-9. doi: 10.1007/s00066-012-0289-7. Epub 2013 Jan 16.

PMID:
23319256
4.

Intensity-modulated radiotherapy followed by a brachytherapy boost for oropharyngeal cancer.

Al-Mamgani A, Levendag PC, van Rooij P, Meeuwis CA, Sewnaik A, Teguh DN.

Head Neck. 2013 Dec;35(12):1689-97. doi: 10.1002/hed.23244. Epub 2013 Mar 9.

PMID:
23483648
5.

Effect of radiation techniques in treatment of oropharynx cancer.

Rusthoven KE, Raben D, Ballonoff A, Kane M, Song JI, Chen C.

Laryngoscope. 2008 Apr;118(4):635-9. doi: 10.1097/MLG.0b013e31815fdf0e.

PMID:
18176348
6.

Prospective functional outcomes in sequential population based cohorts of stage III/ IV oropharyngeal carcinoma patients treated with 3D conformal vs. intensity modulated radiotherapy.

Kerr P, Myers CL, Butler J, Alessa M, Lambert P, Cooke AL.

J Otolaryngol Head Neck Surg. 2015 May 13;44:17. doi: 10.1186/s40463-015-0068-4.

7.

A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.

Lohia S, Rajapurkar M, Nguyen SA, Sharma AK, Gillespie MB, Day TA.

JAMA Otolaryngol Head Neck Surg. 2014 Apr;140(4):331-7. doi: 10.1001/jamaoto.2013.6777.

PMID:
24557509
8.
9.

Clinical outcomes for gastric cancer following adjuvant chemoradiation utilizing intensity modulated versus three-dimensional conformal radiotherapy.

Liu GF, Bair RJ, Bair E, Liauw SL, Koshy M.

PLoS One. 2014 Jan 9;9(1):e82642. doi: 10.1371/journal.pone.0082642. eCollection 2014.

10.

Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.

Goenka A, Magsanoc JM, Pei X, Schechter M, Kollmeier M, Cox B, Scardino PT, Eastham JA, Zelefsky MJ.

Eur Urol. 2011 Dec;60(6):1142-8. doi: 10.1016/j.eururo.2011.08.006. Epub 2011 Aug 12.

PMID:
21855208
11.

Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment.

Moretto F, Rampino M, Munoz F, Ruo Redda MG, Reali A, Balcet V, Badellino S, Piva C, Schena M, Airoldi M, Ostellino O, Pecorari G, Ragona R, Ricardi U.

Radiol Med. 2014 Aug;119(8):634-41. doi: 10.1007/s11547-013-0359-7. Epub 2014 Jan 15.

PMID:
24424659
12.

Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance.

Sveistrup J, af Rosenschöld PM, Deasy JO, Oh JH, Pommer T, Petersen PM, Engelholm SA.

Radiat Oncol. 2014 Feb 4;9:44. doi: 10.1186/1748-717X-9-44.

13.

A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma.

Lee NY, de Arruda FF, Puri DR, Wolden SL, Narayana A, Mechalakos J, Venkatraman ES, Kraus D, Shaha A, Shah JP, Pfister DG, Zelefsky MJ.

Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):966-74.

PMID:
17145527
15.

Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.

de Arruda FF, Puri DR, Zhung J, Narayana A, Wolden S, Hunt M, Stambuk H, Pfister D, Kraus D, Shaha A, Shah J, Lee NY.

Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):363-73. Epub 2005 May 31.

PMID:
15925451
16.

Toxicity, quality of life, and functional outcomes of 176 hypopharyngeal cancer patients treated by (chemo)radiation: the impact of treatment modality and radiation technique.

Al-Mamgani A, Mehilal R, van Rooij PH, Tans L, Sewnaik A, Levendag PC.

Laryngoscope. 2012 Aug;122(8):1789-95. doi: 10.1002/lary.23387.

PMID:
22833307
17.

Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.

Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, Leung SF, Zee B, Chan AT.

Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1440-50.

PMID:
15590175
18.

Highly-conformal intensity-modulated radiotherapy reduced toxicity without jeopardizing outcome in patients with paranasal sinus cancer treated by surgery and radiotherapy or (chemo)radiation.

Al-Mamgani A, Monserez D, Rooij Pv, Verduijn GM, Hardillo JA, Levendag PC.

Oral Oncol. 2012 Sep;48(9):905-11. doi: 10.1016/j.oraloncology.2012.03.024. Epub 2012 May 12.

PMID:
22584070
19.

Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.

Chao KS, Ozyigit G, Blanco AI, Thorstad WL, Deasy JO, Haughey BH, Spector GJ, Sessions DG.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):43-50.

PMID:
15093897
20.

Intensity-modulated radiotherapy for laryngeal and hypopharyngeal cancer: minimization of late dysphagia without jeopardizing tumor control.

Modesto A, Laprie A, Vieillevigne L, Graff P, Sarini J, Vergez S, Delord JP, Farenc JC, Vigarios E, Filleron T, Rives M.

Strahlenther Onkol. 2015 Mar;191(3):225-33. doi: 10.1007/s00066-014-0767-1. Epub 2014 Nov 1.

PMID:
25367098

Supplemental Content

Support Center